Robert Francomano is Chief Commercial Officer of SELLAS Life Sciences Group, Inc.. Currently has a direct ownership of 40,918 shares of SLS, which is worth approximately $51,556. The most recent transaction as insider was on Jan 22, 2024, when has been sold 20,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.9K
0% 3M change
240.98% 12M change
Total Value Held $51,556

Robert Francomano Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 22 2024
BUY
Grant, award, or other acquisition
-
20,000 Added 32.83%
40,918 Common Stock
Dec 06 2023
SELL
Other acquisition or disposition
$1,168 $1.08 p/Share
1,082 Reduced 4.92%
20,918 Class A Common Stock
Feb 02 2023
BUY
Grant, award, or other acquisition
-
12,000 Added 50.0%
12,000 Common Stock
RF

Robert Francomano

Chief Commercial Officer
New York, NY

Track Institutional and Insider Activities on SLS

Follow SELLAS Life Sciences Group, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLS shares.

Notify only if

Insider Trading

Get notified when an Sellas Life Sciences Group, Inc. insider buys or sells SLS shares.

Notify only if

News

Receive news related to SELLAS Life Sciences Group, Inc.

Track Activities on SLS